Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Psychiatry Res Neuroimaging ; 256: 15-20, 2016 Oct 30.
Artículo en Inglés | MEDLINE | ID: mdl-27640073

RESUMEN

Quality of life (QOL) has been recently recognized as the central purpose of healthcare, and positive affect is one of the core dimension of QOL. However, positive affect among patients with dementia or Alzheimer's disease (AD) has not received much attention in the medical research field. One hundred sixteen consecutive patients with AD were recruited from the outpatient units of the Memory Clinic of Okayama University Hospital. The positive affect score was evaluated using the positive affect domain of the Quality of Life questionnaire for Dementia (QOL-D). Patients underwent brain SPECT with 99mTc-ethylcysteinate dimer. Positive affect scores were inversely related to apathy scores, subjective depressive scores, and delusion scores. After removing the effects of age, sex, duration of education, and cognitive function, positive affect scores showed a significant correlation with regional cerebral blood flow in the left premotor and superior frontal gyri. The left premotor and superior frontal area is significantly involved in the pathogenesis of the decrease of positive affect in AD. Apathy and depression are closely related to the prefrontal area in AD, and they may affect the relationship between positive affect and the left prefrontal area.


Asunto(s)
Afecto/fisiología , Enfermedad de Alzheimer/fisiopatología , Enfermedad de Alzheimer/psicología , Encéfalo/fisiopatología , Circulación Cerebrovascular/fisiología , Lóbulo Frontal/fisiopatología , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/diagnóstico por imagen , Apatía/fisiología , Encéfalo/diagnóstico por imagen , Cisteína/análogos & derivados , Depresión/diagnóstico por imagen , Depresión/fisiopatología , Depresión/psicología , Femenino , Lóbulo Frontal/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Compuestos de Organotecnecio , Calidad de Vida/psicología , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios , Tomografía Computarizada de Emisión de Fotón Único
2.
Psychiatry Res ; 221(1): 86-91, 2014 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-24296273

RESUMEN

Depressive symptoms are common in patients with Alzheimer's disease (AD) and increase the caregiver burden, although the etiology and pathologic mechanism of depressive symptoms in AD patients remain unclear. In this study, we tried to clarify the cerebral blood flow (CBF) correlates of depressive symptoms in AD, excluding the effect of apathy and anxiety. Seventy-nine consecutive patients with AD were recruited from outpatient units of the Memory Clinic of Okayama University Hospital. The level of depressive symptoms was evaluated using the depression domain of the Neuropsychiatric Inventory (NPI). The patients underwent brain SPECT with 99mTc-ethylcysteinate dimer. After removing the effects of age, anxiety and apathy scores of NPI, and five subscales of Addenbrooke's Cognitive Examination-revised (ACE-R), correlation analysis of NPI depression scores showed a significant cluster of voxels in the left middle frontal gyrus (Brodmann area 9), similar to the areas in the simple correlation analysis. The dorsolateral prefrontal area is significantly involved in the pathogenesis of depressive symptoms in AD, and the area on the left side especially may be closely related to the depressive symptoms revealed by NPI.


Asunto(s)
Enfermedad de Alzheimer/psicología , Circulación Cerebrovascular/fisiología , Depresión/patología , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/diagnóstico por imagen , Cuidadores/psicología , Corteza Cerebral/patología , Cisteína/análogos & derivados , Depresión/complicaciones , Trastorno Depresivo/diagnóstico por imagen , Femenino , Lóbulo Frontal/patología , Humanos , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas/estadística & datos numéricos , Compuestos de Organotecnecio , Escalas de Valoración Psiquiátrica , Radiofármacos , Tomografía Computarizada de Emisión de Fotón Único/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA